Mouthwash vs. COVID: small study tests if a rinse cuts virus in breath
NCT ID NCT04931004
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This early study tested whether over-the-counter mouthwash could lower the amount of SARS-CoV-2 virus people breathe out. 34 adults with recent COVID-19 used mouthwash or water, and researchers measured virus in their breath and saliva before and after rinsing. The goal was to see if mouthwash might reduce how much virus spreads into the air, not to treat or prevent illness.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- mouthwash (cetylpyridinium chloride)
- What this could lead to
- If mouthwash temporarily lowers virus in breath, it might help reduce spread in close-contact settings.
- What could go wrong
- Very early, tiny study (34 people). Only measures short-term viral load in breath/saliva, not infection or transmission. Mouthwash cannot treat or prevent COVID-19.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID19 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Hospital
Newark, New Jersey, 07103, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a different way of pedaling rebuild muscles after severe COVID-19?
- Ancient herbs take on long COVID: a trial tests whether chinese medicine can soothe persistent fatigue
- Can a 15-Minute chat at a testing site boost COVID-19 vaccination?
- E-Ink screens in ERs could boost patient satisfaction
- Massive study tracks how lockdowns shaped mental health across america
- Hidden danger: study probes blood clot risk in cancer patients with COVID-19